217 related articles for article (PubMed ID: 5050745)
1. [Therapeutic properties of xanthine nicotinate in the treatment of obliterating arteriopathies].
Tardito E; Azzolini A; De Cristofaro A; Papacharalambus D
Minerva Cardioangiol; 1972; 20(7):369-89. PubMed ID: 5050745
[No Abstract] [Full Text] [Related]
2. [The vasoactivogram in the treatment of peripheral arteriopathies].
Romeo S; Spinella G; Sciacchitanto D
Angiologia; 1975; 27(1):7-25. PubMed ID: 1111377
[No Abstract] [Full Text] [Related]
3. [On the treatment of "intermittent claudication" in chronic peripheral obliterating arteriopathies of the lower extremities caused by arteriosclerosis and Buerger's disease].
Seghezzi R; Pedroni G; Borri P
Chir Ital; 1967; 19():Suppl 2:222+. PubMed ID: 5190600
[No Abstract] [Full Text] [Related]
4. [Hemokinetic and metabolic action of 7-2-(3-pyridyl-methylamino)-ethyl-theophylline nicotinate as a basis of medical treatment of chronic obliterating peripheral arteriopathy].
Cascio F
Minerva Cardioangiol; 1973 Nov; 21(11):715-31. PubMed ID: 4776567
[No Abstract] [Full Text] [Related]
5. [Clinical considerations and functional data on the use of the association of kallikrein and meso-inositol hexanicotinate in the therapy of obliterating arteriopathy].
Blasi A; Licciardello M
Clin Ter; 1966 Jul; 38(2):121-58. PubMed ID: 5990194
[No Abstract] [Full Text] [Related]
6. [Effect of surheme on improved blood flow in limbs].
Wesolowski J; Hubl S; Godziemba-Maliszewska E
Wiad Lek; 1972 Jul; 25(14):1297-300. PubMed ID: 5054661
[No Abstract] [Full Text] [Related]
7. [Treatment of organic diseases of peripheral arteries with nicotinic acid derivatives].
Liszewska D; Lukasik E
Pol Tyg Lek; 1967 May; 22(21):794-6. PubMed ID: 6041002
[No Abstract] [Full Text] [Related]
8. [Therapy of peripheral arterial circulation disorders using 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191)].
Denck H
Arzneimittelforschung; 1973 Apr; 23(4):571-3. PubMed ID: 4740236
[No Abstract] [Full Text] [Related]
9. [Medical treatment of obliterating peripheral arteriopathies, especially arteriosclerosis].
Scaffidi V
Minerva Med; 1975 Jan; 66(2):55-65. PubMed ID: 1113917
[TBL] [Abstract][Full Text] [Related]
10. [Therapy of peripheral obliterating arteriopathies with intra-arterial perfusions of dextran of low molecular weight and vasodilator agents].
Buccellato C; Di Lorenzo GD
Minerva Chir; 1967 Jun; 22(11):692-5. PubMed ID: 6050666
[No Abstract] [Full Text] [Related]
11. [Experiences with the treatment of peripheral vascular diseases with Xavin].
Brücknerová O
Vnitr Lek; 1973 Apr; 19(4):379-86. PubMed ID: 4699159
[No Abstract] [Full Text] [Related]
12. [On the treatment of cerebral nutrition disorders. A double blind study].
Kirchberger F; Kehl R; Gutmann W
Med Welt; 1969 Jul; 27():1542-6. PubMed ID: 4895204
[No Abstract] [Full Text] [Related]
13. [Current news in the pharmacological and surgical treatment of chronic, peripheral, obliterating arterial diseases of the lower limbs].
Argenteri A; Bagliani A; Borri P; Ugolini U
Clin Ter; 1974 Aug; 70(3):281-91. PubMed ID: 4423739
[No Abstract] [Full Text] [Related]
14. Regression of peripheral atherosclerosis during therapy with high doses of nicotinic acid.
Ost CR; Sténson S
Scand J Clin Lab Invest Suppl; 1967; 99():241-5. PubMed ID: 6056927
[No Abstract] [Full Text] [Related]
15. [Treatment of arteriopathies of limbs by xanthinol nicotinate].
Elbaz C
Phlebologie; 1969; 22(1):105-11. PubMed ID: 5775643
[No Abstract] [Full Text] [Related]
16. Vasodilator drugs in the treatment of peripheral arterial insufficiency.
Hansteen V; Lorentsen E
Acta Med Scand Suppl; 1974; 556():3-62. PubMed ID: 4366049
[No Abstract] [Full Text] [Related]
17. [Effects of nicergoline in peripheral arteriopathies of the lower limbs. Double-blind study].
Coscia M
Minerva Cardioangiol; 1972 Sep; 20(9):497-504. PubMed ID: 4561065
[No Abstract] [Full Text] [Related]
18. [Medical treatment of acute arterial obliteration in the limbs].
Serradimigni A; Bory M; Poggi L; Audier M
Rev Atheroscler (Paris); 1968; 10(2):3-8. PubMed ID: 5759950
[No Abstract] [Full Text] [Related]
19. Pyridinolcarbamate, bradykinin antagonist, in patients suffering from arteriosclerosis obliterans and thromboangiitis obliterans (Buerger's disease); a preliminary report on the treatment of human atherosclerosis.
Shimamoto T; Atsumi T
Jpn Heart J; 1965 Sep; 6(5):407-15. PubMed ID: 5294603
[No Abstract] [Full Text] [Related]
20. [Mydocalm administered in electrophoresis].
Chmielewski F
Pol Tyg Lek; 1971 Jul; 26(30):1170-2. PubMed ID: 5092988
[No Abstract] [Full Text] [Related]
[Next] [New Search]
